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Letter to Editor
Vitamin D deficiency rickets in a child with xeroderma pigmentosum
Xeroderma pigmentosum (XP) is a rare autosomal recessive genetic disorder of DNA repair characterized by an extreme sensitivity to ultraviolet (UV) rays from 
sunlight and an inability to repair damage caused by UV light [1]. 
It is a genetically heterogeneous genodermatosis and is classified 
into several groups based on the genes involved [2]. Till date, 
mutations of nine genes have been found to be associated with this 
disorder [3]. The most common form is related to the mutations 
in XP, complementation (XPC) gene (XPC Group C) located on 
chromosome 3 [3]. The incidence of XP appears to be low in 
India as compared to several other countries such as Pakistan, 
Egypt, and Nigeria where the rates of consanguinity are high [2].
In patients with XP, sun exposure causes severe sunburn, and 
most of the children develop freckling of the skin in sun-exposed 
areas by 2 years of age. The exposure to sunlight also results in 
dry skin and changes in skin pigmentation. Patients may also 
develop the ocular surface disease, oral lesions, and neurological 
problems [1,2]. There is no cure available for these patients except 
avoiding the sun exposure. In addition, patients with XP need 
to avoid the high-intensity light sources such as energy saving 
fluorescent lamps which emit high levels of UV radiation [2]. The 
lack of ability to repair the UV-mediated DNA damage increases 
the risk of skin cancers [1]. Due to such drastic effects of sun 
exposure, patients with XP are advised strict photoprotection 
which often hampers the cutaneous synthesis of Vitamin D and 
results in Vitamin D deficiency (VDD) if adequate oral Vitamin 
D supplementation is not provided.
A 9-year-old boy presented with progressive lateral bowing 
of legs for the past 2 years. Since infancy, he had dryness 
and scaling of skin along with increased pigmentation and 
severe photosensitivity forcing parents to avoid sun exposure. 
There were no systemic complaints and no family history of 
a similar disorder. Skin examination revealed dry, scaly and 
hyperpigmented skin with interspersed hypopigmented areas, 
and actinic keratosis over the back suggesting a diagnosis of 
XP (Fig. 1a). Physical examination revealed signs of rickets 
including rachitic rosary, widening of wrists and genu valgum 
(Fig. 1b). Ocular, neurological and systemic examinations were 
unremarkable.
Biochemical investigations revealed normal serum calcium 
(8.9 mg/dL, normal range 8.8–10.2 mg/dL), low normal serum 
phosphate (4.0 mg/dL, normal range 3.6–5.8 mg/dL), and 
markedly elevated alkaline phosphatase (1325 U/L, normal 
range 86–315 U/L). Serum 25 - dihydroxyvitamin D was very 
low (<3 ng/mL, normal >20 ng/mL) while serum parathyroid 
hormone was elevated (484.4 pg/mL, normal range 15–65 pg/
mL). Radiographs revealed splaying and fraying of metaphyseal 
ends of femur and tibia along with valgus deformity (Fig. 1c). 
A diagnosis of VDD rickets was made, and the patient was 
given cholecalciferol (60000 IU/day for 10 days followed by 
1000 IU/day). Repeat laboratory evaluation 4 weeks later showed 
normal biochemical parameters. Lifelong oral cholecalciferol 
supplementation (1000 IU/day) was advised.
Several skin disorders which require photoprotection to 
avoid exacerbation of symptoms predispose patients to VDD [4]. 
XP is one such disorder characterized by defective repair of UV 
irradiation-induced DNA damage and >10,000-fold higher risk 
to develop sunlight-induced skin cancer [5]. Patients are advised 
strict photoprotection to prevent UV-induced DNA damage [1,5]. 
Such rigorous photoprotection often results in VDD manifesting 
as rickets or osteomalacia as cutaneous production of Vitamin 
D is also UV-mediated [6]. VDD is indeed common in XP 
patients who do not receive adequate oral Vitamin D. In a recent 
study from Japan, all the 21 patients with XP had Vitamin D 
levels <20 ng/mL; 76% had levels as low as <10 ng/mL [5]. 
The authors recommended lifelong Vitamin D supplementation 
(1000 IU/day) to avoid unfavorable skeletal consequences in 
patients with XP [5].
Furthermore, improving the Vitamin D status would be 
beneficial for patients with XP as recent epidemiological data 
suggest that higher Vitamin D levels are associated with reduced 
risk and improved survival of patients with skin cancers [7]. Our 
case highlights the need for oral Vitamin D supplementation in 
patients with XP and the deleterious skeletal consequences if 
the same is not provided. In our country, the comprehensive 
care of children with XP does not often include provision of 
Vitamin D supplements probably due to focus on the more 
troublesome disease complications [2] or lack of realization 
of VDD and its consequences [8,9]. Furthermore, physicians 
often avoid using larger supplementation doses of Vitamin D 
in children due to fear of hypervitaminosis D; although this 
complication occurs only if there is an underlying condition 
such as a granulomatous disease-causing overproduction of 
1,25 dihydroxyvitamin D [10].
Current evidence supports the provision of at least 1000 IU/
day of Vitamin D in patients with XP; although the requirements 
in Indian children may be higher due to several factors [5,9]. The 
treating physicians should routinely prescribe oral Vitamin D as 
part of the standard care of patients with XP.
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Figure 1: Photograph showing dry, scaly and hyperpigmented skin 
(a), genu valgum (b) and changes of rickets in the metaphyses of 
femur and tibia (c)
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